How do hospital characteristics and ties relate to the uptake of second-generation biosimilars? A longitudinal analysis of Portuguese NHS hospitals, 2015-2021.

Julian Perelman Filipa Duarte-RamosAntónio Melo GouveiaLuis PinheiroFrancisco RamosSabine Vogler Ceu Mateus

Published in: Expert review of pharmacoeconomics & outcomes research (2022)

The findings suggest a need for capacity-building on biosimilar prescribing, including for doctors of academic hospitals and those working in settings where high biosimilar use would be expected.

Keyphrases

healthcare
primary care
adverse drug
medical students
patient safety
emergency department
drug induced